TY - JOUR
T1 - Low- and high-density lipoprotein cholesterol goal attainment in dyslipidemic women
T2 - The Lipid Treatment Assessment Project (L-TAP) 2
AU - Santos, Raul D.
AU - Waters, David D.
AU - Tarasenko, Lisa
AU - Messig, Michael
AU - Jukema, J. Wouter
AU - Ferrières, Jean
AU - Verdejo, Juan
AU - Chiang, Cheng Wen
N1 - Funding Information:
The L-TAP 2 study was funded by Pfizer Inc (New York, NY). The authors are solely responsible for the design and conduct of this study, all study analyses, and the drafting and editing of the paper and its final contents. Assistance in manuscript formatting and preparation of figures was provided by UBC Scientific Solutions Ltd. and funded by Pfizer Inc.
PY - 2009/11
Y1 - 2009/11
N2 - Background: Differences between women and men have been documented for both diagnostic testing and treatment in cardiology. This analysis evaluates whether low-density lipoprotein cholesterol (LDL-C) success rates according to current guidelines and high-density lipoprotein cholesterol (HDL-C) levels differ by gender in the L-TAP 2 population. Methods: Patients aged ≥20 years with dyslipidemia on stable lipid-lowering therapy were assessed in 9 countries between September 2006 and April 2007. Low-density lipoprotein cholesterol goal attainment by cardiovascular risk level and region and determinants of low HDL-C were compared between genders. Results: Of 9,955 patients (45.3% women) evaluated, women had a significantly lower overall LDL-C success rate than men (71.5% vs 73.7%, P = .014), due entirely to the difference in the high-risk/coronary heart disease (CHD) group (LDL-C goal
AB - Background: Differences between women and men have been documented for both diagnostic testing and treatment in cardiology. This analysis evaluates whether low-density lipoprotein cholesterol (LDL-C) success rates according to current guidelines and high-density lipoprotein cholesterol (HDL-C) levels differ by gender in the L-TAP 2 population. Methods: Patients aged ≥20 years with dyslipidemia on stable lipid-lowering therapy were assessed in 9 countries between September 2006 and April 2007. Low-density lipoprotein cholesterol goal attainment by cardiovascular risk level and region and determinants of low HDL-C were compared between genders. Results: Of 9,955 patients (45.3% women) evaluated, women had a significantly lower overall LDL-C success rate than men (71.5% vs 73.7%, P = .014), due entirely to the difference in the high-risk/coronary heart disease (CHD) group (LDL-C goal
UR - http://www.scopus.com/inward/record.url?scp=70350233482&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=70350233482&partnerID=8YFLogxK
U2 - 10.1016/j.ahj.2009.08.009
DO - 10.1016/j.ahj.2009.08.009
M3 - Article
C2 - 19853709
AN - SCOPUS:70350233482
SN - 0002-8703
VL - 158
SP - 860
EP - 866
JO - American Heart Journal
JF - American Heart Journal
IS - 5
ER -